Annual Net Margin
-131.59%
+347.67%+72.54%
31 December 2023
Summary:
Protagonist Therapeutics annual net profit margin is currently -131.59%, with the most recent change of +347.67% (+72.54%) on 31 December 2023. During the last 3 years, it has risen by +99.48% (+43.05%). PTGX annual net margin is now -4.54% below its all-time high of -125.87%, reached on 31 December 2018.PTGX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-710.37%
+24.36%+3.32%
30 September 2024
Summary:
Protagonist Therapeutics quarterly net profit margin is currently -710.37%, with the most recent change of +24.36% (+3.32%) on 30 September 2024. PTGX quarterly net margin is now -973.55% below its all-time high of 81.32%, reached on 31 March 2024.PTGX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.5% | - |
| 3 y3 years | +43.0% | -116.2% |
| 5 y5 years | -4.5% | -79.3% |
PTGX Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +72.5% | -973.5% | +85.1% |
| 5 y | 5 years | -4.5% | +99.6% | -973.5% | +85.1% |
| alltime | all time | -4.5% | +99.6% | -973.5% | +85.1% |
Protagonist Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -710.37%(-3.3%) |
| June 2024 | - | -734.73%(-1003.5%) |
| Mar 2024 | - | 81.32%(+78.5%) |
| Dec 2023 | -131.59%(-72.5%) | 45.56%(-101.0%) |
| Dec 2022 | -479.26%(+4.4%) | - |
| June 2022 | - | -4777.30%(+5771.1%) |
| Mar 2022 | - | -81.37%(-81.0%) |
| Dec 2021 | -458.94%(+98.6%) | -428.30%(+30.3%) |
| Sept 2021 | - | -328.64%(-75.9%) |
| June 2021 | - | -1361.68%(+251.2%) |
| Mar 2021 | - | -387.75%(+16.0%) |
| Dec 2020 | -231.07% | -334.27%(+464.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | -59.20%(-81.0%) |
| June 2020 | - | -312.39%(-43.3%) |
| Mar 2020 | - | -550.59%(-14.5%) |
| Dec 2019 | -33.41 K%(>+9900.0%) | -643.66%(+62.4%) |
| Sept 2019 | - | -396.26%(-56.2%) |
| Mar 2019 | - | -904.04%(+53.4%) |
| Dec 2018 | -125.87%(-31.7%) | -589.25%(+312.6%) |
| Sept 2018 | - | -142.80%(+92.4%) |
| June 2018 | - | -74.21%(+4.4%) |
| Mar 2018 | - | -71.06%(+162.7%) |
| Dec 2017 | -184.20% | -27.05%(-50.8%) |
| Sept 2017 | - | -54.95% |
FAQ
- What is Protagonist Therapeutics annual net profit margin?
- What is the all time high annual net margin for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual net margin year-on-year change?
- What is Protagonist Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Protagonist Therapeutics?
What is Protagonist Therapeutics annual net profit margin?
The current annual net margin of PTGX is -131.59%
What is the all time high annual net margin for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual net profit margin is -125.87%
What is Protagonist Therapeutics annual net margin year-on-year change?
Over the past year, PTGX annual net profit margin has changed by +347.67% (+72.54%)
What is Protagonist Therapeutics quarterly net profit margin?
The current quarterly net margin of PTGX is -710.37%
What is the all time high quarterly net margin for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly net profit margin is 81.32%